News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Welch Allyn Debuts Monitor With Tech From Masimo Corporation (MASI), Covidien plc (COV), EarlySense


2/11/2014 8:55:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Welch Allyn debuts a new Connex clinical surveillance system featuring monitoring technology from Masimo, Covidien and EarlySense. Welch Allyn said its new Connex clinical surveillance system includes technology from a pair of rivals in the patient monitoring space, Masimo (NSDQ:MASI) and Covidien (NYSE:COV), as well as EarlySense. The Connex platform, which transmits captured vital sign data directly into the patient's electronic medical record, incorporates Masimo's acoustic respiration technology, Microstream end-tidal carbon dioxide technology from Covidien and EarlySense's contact-free motion, heart rate and respiratory rate monitoring, according to a press release.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES